These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 12888935)
1. Noninvasive assessment of neoplastic angiogenesis: the role of magnetic resonance imaging. Abu-Hajir M; Rand SD; Krouwer HG; Schmainda KM Semin Thromb Hemost; 2003 Jun; 29(3):309-15. PubMed ID: 12888935 [TBL] [Abstract][Full Text] [Related]
2. Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect. Szentirmai O; Baker CH; Lin N; Szucs S; Takahashi M; Kiryu S; Kung AL; Mulligan RC; Carter BS Neurosurgery; 2006 Feb; 58(2):365-72; discussion 365-72. PubMed ID: 16462491 [TBL] [Abstract][Full Text] [Related]
3. [NMR perfusion imaging: applications to the study of brain tumor angiogenesis]. Le Bas JF; Kremer S; Grand S; Rémy C; Le Duc G; Tropres I; Fonchy E; Peoc'h M; Szabo de Edelenyi F; Estève F; Rubin C; Berger F; Benabid AL; Decorps M Bull Acad Natl Med; 2000; 184(3):557-67. PubMed ID: 10989552 [TBL] [Abstract][Full Text] [Related]
4. A noninvasive multimodal technique to monitor brain tumor vascularization. Saxena V; Gonzalez-Gomez I; Laug WE Phys Med Biol; 2007 Sep; 52(17):5295-308. PubMed ID: 17762087 [TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma. Rosen MA; Schnall MD Clin Cancer Res; 2007 Jan; 13(2 Pt 2):770s-776s. PubMed ID: 17255308 [TBL] [Abstract][Full Text] [Related]
6. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. Winter PM; Caruthers SD; Kassner A; Harris TD; Chinen LK; Allen JS; Lacy EK; Zhang H; Robertson JD; Wickline SA; Lanza GM Cancer Res; 2003 Sep; 63(18):5838-43. PubMed ID: 14522907 [TBL] [Abstract][Full Text] [Related]
7. Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment. Cuenod CA; Fournier L; Balvay D; Guinebretière JM Abdom Imaging; 2006; 31(2):188-93. PubMed ID: 16447089 [TBL] [Abstract][Full Text] [Related]
9. Dynamic magnetic resonance perfusion imaging of brain tumors. Covarrubias DJ; Rosen BR; Lev MH Oncologist; 2004; 9(5):528-37. PubMed ID: 15477637 [TBL] [Abstract][Full Text] [Related]
10. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. Hakyemez B; Erdogan C; Ercan I; Ergin N; Uysal S; Atahan S Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107 [TBL] [Abstract][Full Text] [Related]
11. Tumor microvascular changes in antiangiogenic treatment: assessment by magnetic resonance contrast media of different molecular weights. Turetschek K; Preda A; Novikov V; Brasch RC; Weinmann HJ; Wunderbaldinger P; Roberts TP J Magn Reson Imaging; 2004 Jul; 20(1):138-44. PubMed ID: 15221819 [TBL] [Abstract][Full Text] [Related]
12. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas. Law M; Oh S; Johnson G; Babb JS; Zagzag D; Golfinos J; Kelly PJ Neurosurgery; 2006 Jun; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889 [TBL] [Abstract][Full Text] [Related]
13. Volumetric computed tomography (VCT): a new technology for noninvasive, high-resolution monitoring of tumor angiogenesis. Kiessling F; Greschus S; Lichy MP; Bock M; Fink C; Vosseler S; Moll J; Mueller MM; Fusenig NE; Traupe H; Semmler W Nat Med; 2004 Oct; 10(10):1133-8. PubMed ID: 15361864 [TBL] [Abstract][Full Text] [Related]
14. Dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in pediatric patients. Cha S Neuroimaging Clin N Am; 2006 Feb; 16(1):137-47, ix. PubMed ID: 16543089 [TBL] [Abstract][Full Text] [Related]
15. Imaging tumor angiogenesis: functional assessment using MDCT or MRI? Goh V; Padhani AR Abdom Imaging; 2006; 31(2):194-9. PubMed ID: 16333695 [TBL] [Abstract][Full Text] [Related]
16. Dynamic susceptibility contrast-enhanced perfusion magnetic resonance (MR) imaging combined with contrast-enhanced MR imaging in the follow-up of immunogene-treated glioblastoma multiforme. Stenberg L; Englund E; Wirestam R; Siesjö P; Salford LG; Larsson EM Acta Radiol; 2006 Oct; 47(8):852-61. PubMed ID: 17050367 [TBL] [Abstract][Full Text] [Related]
18. Assessment of blood volume, vessel size, and the expression of angiogenic factors in two rat glioma models: a longitudinal in vivo and ex vivo study. Valable S; Lemasson B; Farion R; Beaumont M; Segebarth C; Remy C; Barbier EL NMR Biomed; 2008 Nov; 21(10):1043-56. PubMed ID: 18615861 [TBL] [Abstract][Full Text] [Related]
19. Perfusion magnetic resonance imaging in psychiatry. Théberge J Top Magn Reson Imaging; 2008 Apr; 19(2):111-30. PubMed ID: 19363433 [TBL] [Abstract][Full Text] [Related]